Are higher doses of rifaximin more effective for the treatment of small-intestinal bacterial overgrowth?
Nat Clin Pract Gastroenterol Hepatol
.
2006 Jan;3(1):22-3.
doi: 10.1038/ncpgasthep0371.
Authors
Christoph Beglinger
1
,
Lukas Degen
Affiliation
1
Department of Gastroenterology, University Hospital, Basel, Switzerland. beglinger@tmr.ch
PMID:
16397608
DOI:
10.1038/ncpgasthep0371
No abstract available
Publication types
Comment